anmelden
NASDAQ Composite Index
26.225,14
PKT
-410,08
PKT
-1,54
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.02.12 | TTM Technologies buy | Needham & Company, LLC | |
| 08.02.12 | ESCO Technologies buy | Needham & Company, LLC | |
| 08.02.12 | Veeco Instruments neutral | Goldman Sachs Group Inc. | |
| 08.02.12 | Veeco Instruments neutral | Banc of America Securities-Merrill Lynch | |
| 08.02.12 | Apple overweight | Barclays Capital | |
| 08.02.12 | ON Semiconductor buy | D.A. Davidson & Co. | |
| 08.02.12 | Veeco Instruments neutral | Piper Jaffray & Co. | |
| 08.02.12 | Veeco Instruments neutral | Stifel, Nicolaus & Co., Inc. | |
| 07.02.12 | Apple buy | Citigroup Corp. | |
| 07.02.12 | Teva Pharmaceutical Industries equal-weight | Morgan Stanley | |
| 07.02.12 | Alphabet A (ex Google) overweight | JP Morgan Chase & Co. | |
| 06.02.12 | Microchip Technology equal-weight | Barclays Capital | |
| 06.02.12 | Microchip Technology overweight | Barclays Capital | |
| 06.02.12 | Volvo (B) overweight | J.P. Morgan Cazenove | |
| 06.02.12 | Take Two neutral | UBS AG | |
| 06.02.12 | Intel buy | UBS AG | |
| 06.02.12 | Gilead Sciences buy | UBS AG | |
| 06.02.12 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 06.02.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 06.02.12 | BlackBerry hold | Société Générale Group S.A. (SG) | |
| 06.02.12 | Fiserv sector perform | RBC Capital Markets | |
| 06.02.12 | Zions Bancorporation equal-weight | Barclays Capital | |
| 06.02.12 | Apple buy | Société Générale Group S.A. (SG) | |
| 06.02.12 | BlackBerry underperform | Jefferies & Company Inc. | |
| 06.02.12 | Patterson-UTI Energy overweight | Barclays Capital | |
| 06.02.12 | Columbia Sportswear sector perform | RBC Capital Markets | |
| 06.02.12 | Wynn Resorts overweight | Barclays Capital | |
| 06.02.12 | Vertex Pharmaceuticals neutral | Goldman Sachs Group Inc. | |
| 06.02.12 | Royal Gold sector perform | Scotia Capital Markets | |
| 06.02.12 | Gilead Sciences buy | Deutsche Bank Securities | |
| 03.02.12 | Open Text outperform | Morgan Keegan & Co., Inc. | |
| 03.02.12 | Microchip Technology buy | Stifel, Nicolaus & Co., Inc. | |
| 03.02.12 | Gilead Sciences buy | Needham & Company, LLC | |
| 03.02.12 | Patterson-UTI Energy neutral | UBS AG | |
| 03.02.12 | Royal Gold buy | UBS AG | |
| 03.02.12 | BlackBerry neutral | UBS AG | |
| 03.02.12 | Amazon overweight | Morgan Stanley | |
| 03.02.12 | QUALCOMM sector outperform | Scotia Capital Markets | |
| 03.02.12 | Open Text outperform | Raymond James Financial, Inc. | |
| 03.02.12 | Open Text sector outperform | Scotia Capital Markets |